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The taxanes are applied as potent chemotherapy agents in the treatment of esophageal cancer; however, their 
therapeutic usefulness is limited by acquired chemoresistance, which is a common drawback to most anti-cancer drugs. 
In our previous study, to elucidate possible causes for acquisition of resistance, we established three taxane resistance 
esophageal cancer cell lines and found that ABCB1 was upregulated in these cells. However, the responsible mechanisms 
remain unclear. In this study, I explored possible mechanisms that might contribute to upregulated ABCB1 expression in 
taxane resistant cells. ABCB1 amplification was present in taxane resistant cells as shown by significant increases of 
gene copy number. In addition, after treatment with 5-Aza and/or TSA in parental cell TE1, the ABCB1 expression was 
activated, suggesting the involvement of epigenetic mechanism. Moreover, I demonstrated that ABCB1 downstream 
promoter was the dominant promoter in taxane resistant esophageal cancer cell lines and the CpG islands were mostly 
unmethylated in taxane resistant cells when compared to dominantly methylated pattern in parental cells.  
 In conclusion, I propose that ABCB1 gene amplification alongside with alteration in epigenetic mechanism could 
be responsible for acquisition of taxane resistance in esophageal cancer cells. 
 
